NCT02445638

Brief Summary

The objective of this randomized, single blinded cross-over study is to investigate effects of daily egg versus yolk-free egg substitute consumption on High Density Lipoprotein (HDL) composition and function in a population of overweight and obese postmenopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 15, 2015

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2017

Completed
Last Updated

January 24, 2019

Status Verified

January 1, 2019

Enrollment Period

2.4 years

First QC Date

May 11, 2015

Last Update Submit

January 22, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Apo A-1 concentration

    The concentration of HDL Apo A-1 will be measured at baseline and after 4 weeks of whole egg, and after 4 weeks of yolk-free egg consumption, in randomized order.

    4 weeks

Secondary Outcomes (2)

  • Change from baseline HDL function

    4 weeks

  • Change from baseline HDL composition

    4 weeks

Study Arms (2)

Whole egg

ACTIVE COMPARATOR

Subjects will be provided with a daily breakfast meal containing the equivalent of 2 whole eggs for 4 weeks.

Other: Whole egg

Yolk-free egg

PLACEBO COMPARATOR

Subjects will be provided with a daily breakfast meal containing the equivalent of 2 yolk-free eggs for 4 weeks.

Other: Yolk-free egg

Interventions

Subjects will be provided with the equivalent of 2 whole eggs daily.

Whole egg

Subjects will be provided with the equivalent of 2 yolk-free eggs daily.

Yolk-free egg

Eligibility Criteria

Age45 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • years old
  • Overweight or obese (BMI 25-35 kg/m2)
  • Post-menopausal (confirmed by clinical hormone levels assessed at screening if within one year of last menses)
  • Plasma HDL cholesterol greater than or equal to 50 mg/dL.

You may not qualify if:

  • Documented chronic diseases including diabetes, thyroid disease, metabolic syndrome, cancer (active), or previous cardiovascular events
  • Having 3 or more traits of Metabolic Syndrome
  • Egg allergy or multiple food allergies or food intolerances that would significantly limit food intake
  • Smoker
  • Current consumption more than 1 alcoholic drink/ day
  • Extreme dietary or exercise patterns
  • Recent weight fluctuations (greater than 10% in the last six months)
  • Anemia
  • Taking prescription lipid medications or other supplements known to alter lipoprotein metabolism such as isoflavones, red yeast rice, or \> 1 g of fish oil/day.
  • Taking exogenous hormones (i.e. hormone replacement therapy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Davis

Davis, California, 95616, United States

Location

Related Publications (1)

  • Sawrey-Kubicek L, Zhu C, Bardagjy AS, Rhodes CH, Sacchi R, Randolph JM, Steinberg FM, Zivkovic AM. Whole egg consumption compared with yolk-free egg increases the cholesterol efflux capacity of high-density lipoproteins in overweight, postmenopausal women. Am J Clin Nutr. 2019 Sep 1;110(3):617-627. doi: 10.1093/ajcn/nqz088.

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Francene Steinberg, PhD, RD

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2015

First Posted

May 15, 2015

Study Start

May 1, 2015

Primary Completion

September 6, 2017

Study Completion

September 6, 2017

Last Updated

January 24, 2019

Record last verified: 2019-01

Locations